Graticule Asia Macro Advisors LLC Amgen Inc Transaction History

Graticule Asia Macro Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $945,520 - $1.1 Million	-5,300 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $722,631 - $814,671	3,900 Added 278.57%	5,300 $1.1 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $16,605 - $18,651	100 Added 7.69%	1,400 $258,000
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $220,259 - $257,400	1,300 New	1,300 $222,000

3,057

409M

7.19M

6.3M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Graticule Asia Macro Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Graticule Asia Macro Advisors LLC with notifications on news.